In re: McKinsey & Co., Inc. National Prescription Opiate Consultant Litigation

Track this case

Case Number:

3:21-md-02996

Court:

California Northern

Nature of Suit:

Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability

Multi Party Litigation:

Class Action, Multi-district Litigation

Judge:

Charles R. Breyer

Firms

Companies

Government Agencies

Sectors & Industries:

August 23, 2024
McKinsey Opioid Suits Sent Back To NY, Illinois State Courts

A California federal judge has remanded, to their respective state courts, cases brought by dozens of New York municipalities and two Illinois counties against McKinsey & Co. over its alleged role in the opioid crisis, saying the consulting firm's "tortured interpretations of state law" don't give the Golden State jurisdiction.
August 02, 2024
McKinsey's $78M Opioid Deal With Health Plans Gets OK

A California federal judge said Friday he'll approve McKinsey & Co. Inc.'s $78 million deal to resolve claims on behalf of approximately 42,000 third-party payors, with class counsel receiving $15.1 million in fees, after the initial settlement was tweaked due to objections from some plaintiffs' attorneys.
May 20, 2024
McKinsey Can't Nix Pregnant Women's Claims In Opioid MDL

A California federal judge has cut some claims from multidistrict litigation seeking to hold McKinsey & Co. Inc. liable for infant neonatal abstinence syndrome caused by pregnant women's use of opioids, trimming fraud and nuisance-based claims, but allowing conspiracy and aiding-and-abetting claims to proceed against the consulting firm.
April 04, 2024
Tribes And McKinsey Take Final Step In $39.5M Opioid Deal

A California judge signed off Thursday on the completion of a $39.5 million nationwide settlement deal that resolves all opioids litigation brought by federally recognized tribes against McKinsey & Co.
February 02, 2024
McKinsey's $78M Opioid Deal With Health Plans Hits Snag

A California federal judge considering a $78 million deal between third-party payors and McKinsey & Co. in multidistrict litigation over the consulting firm's marketing advice to opioid makers held off on preliminarily approving the deal Friday, instead setting a new hearing date after some plaintiffs' attorneys raised issues with aspects of the deal.
September 27, 2023
McKinsey Strikes $230M Opioid Deal With Gov'ts And Schools

Management consulting giant McKinsey & Co. has struck a deal to pay a total of $230 million to end claims brought by local governments and school districts that its work advising drugmakers contributed to the opioid crisis, according to documents filed late Tuesday in California federal court.
July 20, 2023
Last Claims Tossed In McKinsey Opioid Marketing MDL

A California federal judge on Thursday dismissed the remaining allegations from the caretakers of infants born with neonatal abstinence syndrome caused by their mother's use of opioids before or during pregnancy in multidistrict litigation against McKinsey & Co. Inc., finding the complaint doesn't establish a duty to the parents, or adequately plead their reliance on any purported misrepresentations made by the management consulting firm.
June 30, 2023
Opioid Judge Mulls Liability Of 'Don Draper' McKinsey

A California federal judge expressed doubts Friday about whether McKinsey & Co. should face negligence claims brought by babies born with neonatal abstinence syndrome caused by their mothers' opioid use, probing for evidence that McKinsey knew opioids were addictive when it gave marketing advice as "the Don Draper for the industry."
June 23, 2023
McKinsey Nears Opioid MDL Deal With Tribes, Insurance Plans

Tribes and health insurance plans are nearing a deal with McKinsey & Co. to settle claims the management consultant worked with pharmaceutical companies to push addictive opioids, according to a joint status report filed on Friday.
April 27, 2023
McKinsey, Plaintiffs Spar Over Picking Opioid Bellwether Tribe

Plaintiffs suing McKinsey & Co. for allegedly masterminding schemes to help Purdue Pharma LP and the Sackler family sell addictive opioids have urged a California federal judge to select a Washington state tribe as the first tribal bellwether case, but McKinsey said it wants a more in-depth selection process.

← Previous
1
2
3
Next →